Medical robotics startup Sentante is positioning its newly CE-marked robotic vascular intervention platform as more than a remote surgery system. The company says its technology has been engineered to generate high-quality procedural data that could underpin future AI-assisted endovascular interventions, combining force sensing, catheter motion tracking, and medical imaging into a unified dataset for machine learning. The approach reflects a broader shift in healthcare AI, where the availability of clinically relevant data is becoming as important as advances in robotic hardware.

As artificial intelligence moves beyond digital assistants and software automation into the physical world, robotics companies are increasingly confronting a fundamental challenge: AI systems are only as capable as the data used to train them.

Sentante, a European medical robotics company focused on remote vascular intervention, believes that challenge has slowed progress toward intelligent robotic surgery. Rather than prioritizing autonomous capabilities from the outset, the company has spent several years developing a robotic platform designed to capture comprehensive procedural data during real clinical operations.

Following the CE marking of its robotic endovascular system, Sentante is now beginning commercial deployment across Europe while simultaneously building what it views as one of the industry’s most valuable assets—a structured dataset of expert vascular interventions.

From Robotic Surgery to Physical AI

Unlike traditional AI models that analyze text or images, physical AI systems must understand how to interact safely with the real world. In vascular procedures, that means interpreting subtle tactile cues while navigating delicate blood vessels using guidewires and catheters.

Sentante’s platform simultaneously records force and torque measurements, catheter kinematics, and synchronized fluoroscopy imaging throughout every procedure. According to the company, combining these data streams creates a richer representation of expert clinical decision-making than imaging alone.

That distinction has become increasingly relevant as healthcare providers work to reduce radiation exposure and contrast-agent usage during minimally invasive procedures.

Clinical guidelines encourage physicians to minimize fluoroscopy time and contrast media because prolonged radiation affects both patients and operating staff, while excessive contrast agents can contribute to kidney injury in vulnerable patients.

Reducing imaging, however, also reduces the visual information available during an intervention.

Sentante argues that tactile feedback—the resistance physicians feel through guidewires and catheters—provides critical safety information that conventional imaging cannot capture.

“The image tells you where the device is,” said Dr. Tomas Baltrūnas, Sentante’s co-founder and Chief Medical Officer. “The hand tells you what the vessel is doing.”

Why Force Data Matters

Force sensing remains relatively uncommon in surgical robotics.

Although robotic-assisted surgery has become increasingly common across specialties, many systems have historically relied primarily on visual feedback. Intuitive Surgical’s da Vinci 5, introduced in 2024, marked one of the first major commercial surgical robots to incorporate advanced force feedback, reflecting growing industry recognition that tactile information improves surgical precision.

In endovascular procedures, where thin wires and catheters remain in continuous contact with blood vessel walls, force data may be even more significant.

Small variations in resistance can distinguish routine catheter navigation from potentially dangerous vessel injury—information that may not be visible on two-dimensional fluoroscopic images.

By capturing both physical interaction data and medical imaging simultaneously, Sentante hopes to create training datasets capable of supporting increasingly sophisticated AI-assisted navigation.

Preserving Clinical Expertise

Another differentiator is the company’s motion-mimicking operator interface.

Many robotic catheter systems require physicians to control instruments using joysticks or custom consoles, introducing an additional learning curve and altering natural clinical workflows.

Sentante instead allows physicians to manipulate conventional guidewires and catheters using familiar techniques while the robotic system mirrors those movements remotely.

The company argues this approach preserves authentic procedural behavior while reducing training requirements.

For AI development, that distinction could prove equally important.

Rather than recording how clinicians operate a robotic controller, the system captures the same manual techniques physicians have developed over years of clinical practice.

That potentially expands the pool of training data to include virtually every experienced interventional specialist using the platform.

Building a Foundation for AI-Assisted Intervention

The company has already conducted several high-profile demonstrations designed to validate both its remote surgery capabilities and its data collection architecture.

During the past year, Sentante completed what it describes as the world’s first transatlantic remote thrombectomy performed on perfused human cadaver models. It also carried out a Good Laboratory Practice (GLP) animal study involving 24 remote procedures across three continents.

While these demonstrations primarily showcased remote operation capabilities, they also contributed to the growing procedural dataset the company intends to use for future AI development.

The latest version of the robotic platform incorporates NVIDIA computing hardware, and Sentante says it was among the early developers building medical robotics applications using NVIDIA Isaac for Healthcare, a robotics development framework designed for AI-powered healthcare systems.

Industry Context

The announcement comes as AI and robotics increasingly converge across healthcare.

Companies including Intuitive Surgical, Johnson & Johnson MedTech, Medtronic, Stryker, and CMR Surgical are expanding investments in AI-enabled surgical platforms that combine robotics, computer vision, predictive analytics, and workflow automation.

However, many experts argue that progress toward greater autonomy will depend less on algorithm design than on access to large volumes of high-quality procedural data.

According to McKinsey & Company, AI adoption in healthcare continues accelerating as providers seek technologies that improve clinical outcomes, reduce operational complexity, and enhance physician productivity. Meanwhile, Grand View Research projects sustained growth in the global surgical robotics market as minimally invasive procedures become more widespread.

Enterprise Impact

For hospitals and healthcare systems, robotic platforms are evolving beyond standalone surgical devices into connected data platforms capable of supporting clinical analytics, remote collaboration, and AI-assisted decision-making.

Sentante’s strategy reflects that transition.

By integrating robotic hardware, force sensing, imaging, and AI-ready data collection into a single platform, the company is positioning each clinical procedure as both a patient intervention and a source of future machine learning intelligence.

Commercial deployment of the CE-marked platform is now underway across Europe for peripheral vascular interventions, while remote stroke thrombectomy remains on a separate regulatory pathway.

Although fully autonomous vascular surgery remains a long-term objective for the industry, Sentante’s approach suggests that the next phase of innovation may depend less on pursuing autonomy directly and more on systematically collecting the clinical data required to enable it safely.

Market Landscape

Medical robotics is entering a new phase where AI, force sensing, and multimodal data collection are becoming strategic differentiators. Rather than relying solely on computer vision, next-generation robotic platforms increasingly combine tactile sensing, imaging, and real-time analytics to improve precision and support future AI-assisted interventions.

According to Grand View Research, the global surgical robotics market is expected to expand steadily through the coming decade, driven by demand for minimally invasive procedures and advances in robotic technologies. McKinsey & Company also identifies AI-enabled clinical decision support and intelligent automation as major trends shaping healthcare innovation.

Competition includes Intuitive Surgical, Johnson & Johnson MedTech, Medtronic, Stryker, CMR Surgical, and emerging startups focused on AI-driven robotic intervention platforms.

Top Insights

• Sentante has commercially launched its CE-marked robotic vascular intervention system, designed to collect multimodal procedural data that can support future AI-assisted endovascular surgery.
• The platform combines force and torque sensing, catheter motion tracking, and synchronized fluoroscopy, enabling richer datasets than imaging-only robotic systems.
• A motion-mimicking interface allows physicians to use standard catheters and guidewires, preserving natural clinical techniques while reducing robotic training requirements.
• The company has demonstrated remote thrombectomy procedures and integrated NVIDIA Isaac for Healthcare technologies as part of its AI development roadmap.
• The strategy reflects a broader healthcare trend toward data-centric robotic platforms that pair intelligent software with clinically validated hardware.

Power Tomorrow’s Intelligence — Build It with TechEdgeAI